Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study
Intensive Care Medicine · 2024
DOI: 10.1007/s00134-024-07501-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Intensive Care Medicine, 2024. Verfasst von David Levy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, Paris, France. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Pulmonary Embolism, Thrombolytic Therapy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Despite systemic thrombolysis, a few patients with high-risk pulmonary embolism (PE) remain hemodynamically unstable. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a considerable lifesaving therapy but systemic thrombolysis before cannulation could carry a high risk of hemorrhage and alter the prognosis. METHODS: Between June 2012 and June 2023, we retrospectively analyzed from three intensive care units in Sorbonne University, ECMO-related complications and 90-day mortality for high-risk PE patients who received ECMO without previous systemic thrombolysis compared to those cannulated after systemic thrombolysis failure. Hospital discharge survivors were assessed for long-term health-related quality of life and echocardiographic evaluations. RESULTS: 72 high-risk PE patients [median age 48 (37-61) years, Simplified Acute Physiology Score II (SAPS II) 74 (60-85)] were placed on VA-ECMO for 5 (5-7) days. 31 (43%) patients underwent pre-ECMO thrombolysis (thrombolysis ECMO group, T +) compared to 41 patients (57%, no thrombolysis ECMO group, T-). There was more pre-ECMO cardiac arrest in the thrombolysis ECMO group (94% vs. 67%, p = 0.02). Ninety-day survival was not different between groups (39% vs 46%, log-rank test, p = 0.31). There was no difference in severe hemorrhages (61% vs 59%, p = 1). Twenty-five over 28 patients attended follow-up at a median time of 69 (52-95) months. Long-term quality of life was acceptable and none of them experienced chronic thromboembolic pulmonary hypertension. CONCLUSIONS: Ninety-day survival and bleeding events rates did not differ in patients treated with VA-ECMO after systemic thrombolysis compared to those who were not. Recent systemic thrombolysis, as a single parameter, should not be considered as a contraindication for VA-ECMO in high-risk PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN, Paris, France.
- Service de Médecine Intensive-Réanimation, Institut de Cardiologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Hôpital Pitié-Salpêtrière, 47-83 Boulevard de L'Hôpital, 75013, Paris, France.
- School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
- Department of Health Sciences, University of Milan, Milan, Italy.
- Service de Chirurgie Cardiaque et Thoracique, Institut de Cardiologie, AP-HP, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
- Department of Anesthesiology and Critical Care Medicine, Cardiology Institute, GRC 29, AP-HP, Pitié-Salpêtrière Hospital, Sorbonne University, 47-83 Boulevard de L'Hôpital, 75013, Paris, France.
ORCID-Profile: Matthieu Schmidt
Zitieren
APA
Levy, D., Saura, O., Passarelli, M. T., Lucenteforte, M., Lebreton, G., Bougle, A., Monsel, A., Ortuno, S., Benitha, Y., Hammoudi, N., Assouline, B., Petit, M., Gautier, M., Le Fevre, L., Pineton de Chambrun, M., Juvin, C., Chommeloux, J., Luyt, C. E., Hékimian, G., …, & Schmidt, M. (2024). Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study. Intensive Care Medicine. https://doi.org/10.1007/s00134-024-07501-9
Vancouver
Levy D, Saura O, Passarelli MT, Lucenteforte M, Lebreton G, Bougle A, et al. Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study. Intensive Care Medicine. 2024. doi:10.1007/s00134-024-07501-9
BibTeX
@article{Levy2024,
author = {Levy, David and Saura, Ouriel and Passarelli, Maria Teresa and Lucenteforte, Manuela and Lebreton, Guillaume and Bougle, Adrien and Monsel, Antoine and Ortuno, Sofia and Benitha, Yoël and Hammoudi, Nadjib and Assouline, Benjamin and Petit, Matthieu and Gautier, Melchior and Le Fevre, Lucie and Pineton de Chambrun, Marc and Juvin, Charles and Chommeloux, Juliette and Luyt, Charles-Edouard and Hékimian, Guillaume and Leprince, Pascal and Combes, Alain and Schmidt, Matthieu},
title = {Thrombolysis before venoarterial ECMO for high-risk pulmonary embolism: a retrospective cohort study},
journal = {Intensive Care Medicine},
year = {2024},
doi = {10.1007/s00134-024-07501-9}
}
EUVIMED